These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1533533)

  • 1. Thromboxane synthase inhibitors and receptor antagonists.
    Vermylen J; Deckmyn H
    Cardiovasc Drugs Ther; 1992 Feb; 6(1):29-33. PubMed ID: 1533533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of thromboxane receptor blockade versus thromboxane synthase inhibition on canine arterial graft patency.
    Bech FR; Cronenwett JL; McDaniel MD; Ogletree ML; Freeman DH
    J Vasc Surg; 1990 Aug; 12(2):119-25. PubMed ID: 2143235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9, 11-Azo-12-oxa-15-hydroxyprostanoic acid: a potent thromboxane synthetase inhibitor and a PGH2/TxA2 receptor antagonist.
    Kam ST; Portoghese PS
    Prostaglandins Med; 1979 Nov; 3(5):279-90. PubMed ID: 233035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT).
    Circulation; 1994 Feb; 89(2):588-95. PubMed ID: 8313547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane A2/prostaglandin H2 receptor antagonists. A new therapeutic principle.
    Patscheke H
    Stroke; 1990 Dec; 21(12 Suppl):IV139-42. PubMed ID: 2148033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition.
    Patscheke H; Hornberger W; Zehender H
    Z Kardiol; 1990; 79 Suppl 3():151-4. PubMed ID: 2099038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of combined thromboxane synthase inhibition/receptor blockade with CGS 22652 in a canine model of coronary thrombosis.
    Olson RW; Dotson R; Mathis J; Cohen DS; Webb RL
    Eur J Pharmacol; 1993 May; 236(1):75-87. PubMed ID: 8319746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation by dazoxiben, a thromboxane synthetase inhibitor, of platelet aggregation inhibitory activity of a thromboxane receptor antagonist and of prostacyclin.
    Bertele V; De Gaetano G
    Eur J Pharmacol; 1982 Dec; 85(3-4):331-3. PubMed ID: 6295787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosynthesis and pharmacological modulation of thromboxane in humans.
    Patrono C
    Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane receptors antagonists and/or synthase inhibitors.
    Davì G; Santilli F; Vazzana N
    Handb Exp Pharmacol; 2012; (210):261-86. PubMed ID: 22918735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
    J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane A2 in cardiovascular and renal disorders: is there a defined role for thromboxane receptor antagonists or thromboxane synthase inhibitors?
    Smith EF
    Eicosanoids; 1989; 2(4):199-212. PubMed ID: 2534279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane synthesis inhibitors and receptor antagonists.
    Patrono C
    Thromb Res Suppl; 1990; 11():15-23. PubMed ID: 2148990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic disorders.
    Gresele P; Deckmyn H; Nenci GG; Vermylen J
    Trends Pharmacol Sci; 1991 Apr; 12(4):158-63. PubMed ID: 1829559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of thromboxane metabolism interference on glycemia regulation in rats.
    Nechifor M; Busuioc A; Cocu F
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):555-7. PubMed ID: 2977856
    [No Abstract]   [Full Text] [Related]  

  • 20. The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin.
    Fontana P; Alberts P; Sakariassen KS; Bounameaux H; Meyer JP; Santana Sorensen A
    J Thromb Haemost; 2011 Oct; 9(10):2109-11. PubMed ID: 21777369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.